Prasterone - Genelabs
Alternative Names: Anastar; Aslera; Dehydroepiandrosterone - Genelabs; DHEA - Genelabs; E 10; GL 701; PrestaraLatest Information Update: 24 Oct 2021
At a glance
- Originator Stanford University
- Developer Genelabs Technologies
- Class Androstenols; Anti-inflammatories; Hormonal replacements; Small molecules
- Mechanism of Action Dehydroepiandrosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Systemic lupus erythematosus
Most Recent Events
- 05 Aug 2010 No development reported - Phase-III for Systemic lupus erythematosus in USA (PO)
- 05 Aug 2010 No development reported - Preregistration for Systemic lupus erythematosus in Europe (PO)
- 07 Jan 2009 Genelabs Technologies has been acquired by GlaxoSmithKline